- Home
- MRNA vs TPR Comparison
MRNA vs TPR Comparison
Compare MRNA & TPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- TPR
- Stock Information
- Founded
- MRNA 2010
- TPR 1941
- Country
- MRNA United States
- TPR United States
- Employees
- MRNA N/A
- TPR N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- TPR Apparel
- Sector
- MRNA Health Care
- TPR Consumer Discretionary
- Exchange
- MRNA Nasdaq
- TPR Nasdaq
- Market Cap
- MRNA 16.0B
- TPR 16.8B
- IPO Year
- MRNA 2018
- TPR 2000
- Fundamental
- Price
- MRNA $28.56
- TPR $70.05
- Analyst Decision
- MRNA Hold
- TPR Buy
- Analyst Count
- MRNA 20
- TPR 18
- Target Price
- MRNA $54.82
- TPR $80.72
- AVG Volume (30 Days)
- MRNA 9.3M
- TPR 6.4M
- Earning Date
- MRNA 05-01-2025
- TPR 05-08-2025
- Dividend Yield
- MRNA N/A
- TPR 1.99%
- EPS Growth
- MRNA N/A
- TPR N/A
- EPS
- MRNA N/A
- TPR 3.44
- Revenue
- MRNA $3,236,000,000.00
- TPR $6,776,400,000.00
- Revenue This Year
- MRNA N/A
- TPR $4.13
- Revenue Next Year
- MRNA $23.65
- TPR $3.22
- P/E Ratio
- MRNA N/A
- TPR $20.45
- Revenue Growth
- MRNA N/A
- TPR 0.74
- 52 Week Low
- MRNA $29.25
- TPR $35.23
- 52 Week High
- MRNA $170.47
- TPR $90.85
- Technical
- Relative Strength Index (RSI)
- MRNA 34.78
- TPR 37.38
- Support Level
- MRNA $31.52
- TPR $70.40
- Resistance Level
- MRNA $34.87
- TPR $75.82
- Average True Range (ATR)
- MRNA 1.74
- TPR 2.44
- MACD
- MRNA -0.37
- TPR -0.22
- Stochastic Oscillator
- MRNA 15.53
- TPR 33.56
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TPR Tapestry Inc.
Coach, Kate Spade, and Stuart Weitzman are New York City-based Tapestry's fashion and accessory brands. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (64% of fiscal 2024 sales), Europe, Asia, and elsewhere. Coach (76% of sales) is best known for affordable luxury leather products. Kate Spade (20%) is known for colorful patterns and graphics. Both Coach and Kate Spade specialize in women's handbags and accessories, 69% of Tapestry's fiscal 2024 sales. Stuart Weitzman (4%) generates virtually all its revenue from women's luxury footwear.